Home » Topics » BioWorld Science

BioWorld Science
RSS

SBIR grant supports STRM.BIO's development of EV technology as gene therapy delivery platform

July 27, 2022

Impact Biomedical announces development of Quantum antihistamine

July 27, 2022

Discovery of novel candidates for the treatment of Chagas disease

July 27, 2022

ScinnoHub Pharmaceutical discovers plasmin inhibitors

July 27, 2022

CFB inhibitors identified by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

July 27, 2022

Nonessential but critical, tyrosine plays key role in nutrient sensing

July 26, 2022

New compound advances anoctamin-1 inhibition for analgesia

July 26, 2022

RNF31 as a novel therapeutic target for immunotherapy-refractory cancers

July 26, 2022

Oryzon collaborates with CMTRF to evaluate HDAC6 inhibitors for Charcot-Marie-Tooth disease

July 26, 2022

PsychoGenics to evaluate preclinical antiseizure efficacy of IAMA's selective NKCC1 inhibitors

July 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...